Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Intercept Pharmaceuticals, Inc. ICPT

Set alert

Price alert · ICPT

All alert types
19.00 0.00 0.00%

At close · Nov 7

18.98 Day range 19.01

52-week range unavailable

Open
19.00
Prev close
19.00
Mkt cap
794.69M
Vol
3.91M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
18.98
High
19.01
Forward P/E
8.88
Beta
0.88
Short ratio
5.54
Inst. own
81.30%
Dividend
0.00
Ex-div date
Earnings
Nov 6, 2023
50-d avg
16.63
200-d avg
14.55
1y target
19.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Sep 26, 2023Downgrade: Canaccord Genuity · Buy → Hold
  • Sep 26, 2023Downgrade: HC Wainwright & Co. · Buy → Neutral
  • Sep 26, 2023Rating: RBC Capital · Sector Perform → Sector Perform
  • Sep 26, 2023Downgrade: B. Riley Securities · Buy → Neutral
  • Nov 6, 2023Earnings: —; estimate -0.27; surprise —%
Signals (19)
NameDateAgo
MACD: Sell SignalOct 13, 20233 years ago
SMA: BullishSep 26, 20233 years ago
SMA: BullishSep 26, 20233 years ago
MACD: Buy SignalSep 26, 20233 years ago
RSI: OverboughtSep 26, 20233 years ago
SMA: BearishSep 22, 20233 years ago
SMA: BearishSep 21, 20233 years ago
MACD: Sell SignalSep 20, 20233 years ago
SMA: BullishSep 8, 20233 years ago
SMA: BearishSep 7, 20233 years ago
SMA: BullishSep 6, 20233 years ago
SMA: BullishSep 6, 20233 years ago
SMA: BearishSep 5, 20233 years ago
SMA: BearishSep 5, 20233 years ago
SMA: BullishAug 28, 20233 years ago
SMA: BullishAug 25, 20233 years ago
SMA: BearishAug 23, 20233 years ago
SMA: BullishAug 22, 20233 years ago
MACD: Buy SignalAug 18, 20233 years ago

Analyst view

Consensus: hold

Hold
Price target (mean) 19.00
Ratings (0m) 20 10 buy · 8 hold · 2 sell
  • Strong buy3
  • Buy7
  • Hold8
  • Sell2
  • Strong sell0

Recommendation trend

  • This month 20
  • 1 month ago 14
  • 2 months ago 16
  • 3 months ago 17

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ICPT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.09-0.36 – 0.07-0.50+82.0%90.66M+17.4%9
Next quarter0.220.02 – 0.35-0.77+128.6%79.85M+17.5%6
Current year-1.20-1.43 – -0.766.56-118.3%330.33M+15.6%9
Next year2.141.42 – 2.84-1.20+278.3%358.87M+8.6%10

Upgrades and downgrades

The latest rating changes

ICPT analyst upgrades and downgrades
DateFirmActionFromTo
Sep 26, 2023Canaccord GenuityDowngradeBuyHold
Sep 26, 2023HC Wainwright & Co.DowngradeBuyNeutral
Sep 26, 2023RBC CapitalMaintainedSector PerformSector Perform
Sep 26, 2023B. Riley SecuritiesDowngradeBuyNeutral
Aug 2, 2023Canaccord GenuityMaintainedBuyBuy
Aug 2, 2023HC Wainwright & Co.Reiterated—Buy
Jul 12, 2023HC Wainwright & Co.UpgradeSellBuy
Jun 28, 2023Canaccord GenuityUpgradeHoldBuy
Jun 25, 2023RBC CapitalMaintainedSector PerformSector Perform
Jun 14, 2023RBC CapitalMaintainedSector PerformSector Perform
May 29, 2023B. Riley SecuritiesMaintainedBuyBuy
May 22, 2023NeedhamDowngradeBuyHold
May 22, 2023Canaccord GenuityMaintainedHoldHold
May 22, 2023B of A SecuritiesMaintainedUnderperformUnderperform
May 21, 2023BairdMaintainedOutperformOutperform
May 21, 2023HC Wainwright & Co.DowngradeNeutralSell
May 21, 2023RBC CapitalReiteratedSector PerformSector Perform
May 17, 2023Raymond JamesDowngradeOutperformMarket Perform
Apr 27, 2023Raymond JamesMaintained—Outperform
Apr 9, 2023Piper SandlerMaintained—Overweight
Mar 5, 2023Raymond JamesMaintained—Outperform
Mar 2, 2023NeedhamMaintained—Buy
Mar 2, 2023SVB LeerinkMaintained—Market Perform
Mar 2, 2023RBC CapitalMaintained—Sector Perform
Mar 1, 2023B. Riley SecuritiesMaintainedBuyBuy
Feb 14, 2023RBC CapitalMaintained—Sector Perform
Jan 24, 2023B. Riley SecuritiesMaintainedBuyBuy
Jan 19, 2023Raymond JamesMaintained—Outperform
Nov 15, 2022HC Wainwright & Co.Maintained—Neutral
Nov 1, 2022Raymond JamesMaintained—Outperform